Search Tag: transcatheter heart valve
2016 17 May
New reports from EuroPCR 2016 reveal that half of transcatheter heart valves undergo degeneration within 10 years. Findings from the first study to investigate the long-term durability of these valves were presented at the congress. TAVI has now become increasingly popular among younger patients as well as those with lower surgical risk. Life expectancy...Read more
2014 08 Jul
The one-year survival rate for patients who undergo transcatheter valve-in-valve implantation inside a malfunctioning bioprosthetic valve was 83.2 percent, according to a study by researchers at St. Paul’s Hospital in Vancouver, Canada. With bioprosthetic valves becoming more common than mechanical ones in surgical aortic valve replacement, an evaluation...Read more
2014 22 Jan
Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, announced that a federal jury found Edwards' United States Cribier transcatheter heart valve patent valid, and that Medtronic CoreValve LLC willfully infringes it. Edwards will move to enforce this verdict and intends to seek a permanent...Read more
2014 15 Jan
Enrollment Completed in Trial of High-Risk Patients Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, announced that it received Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) to initiate a single-arm, non-randomised clinical trial of...Read more